Incannex Healthcare (IXHL) to Release Earnings on Thursday

Incannex Healthcare (NASDAQ:IXHL) is projected to announce its Q1 2026 results before the market opens on Thursday, November 13th. Analysts expect the company to announce earnings of ($0.39) per share and revenue of $0.20 million for the quarter. Investors can check the company’s upcoming Q1 2026 earningsummary page for the latest details on the call scheduled for Thursday, November 20, 2025 at 7:00 AM ET.

Incannex Healthcare (NASDAQ:IXHL) last posted its quarterly earnings data on Monday, September 29th. The company reported ($0.25) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.29) by $0.04. The company had revenue of $0.20 million during the quarter, compared to the consensus estimate of $0.20 million.

Incannex Healthcare Stock Performance

NASDAQ IXHL opened at $0.36 on Wednesday. The business’s 50 day moving average price is $0.45 and its 200-day moving average price is $0.40. Incannex Healthcare has a fifty-two week low of $0.08 and a fifty-two week high of $3.12. The company has a market cap of $125.18 million, a P/E ratio of -0.30 and a beta of 7.46.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on IXHL shares. Wall Street Zen upgraded shares of Incannex Healthcare to a “hold” rating in a research report on Friday, July 18th. Weiss Ratings restated a “sell (e+)” rating on shares of Incannex Healthcare in a report on Wednesday, October 8th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, Incannex Healthcare presently has a consensus rating of “Sell”.

About Incannex Healthcare

Incannex Healthcare Inc, a clinical stage pharmaceutical development company, engages in the research, development, and sale of medicinal cannabinoid and psychedelic pharmaceutical products and therapies. It develops products for the treatment of obstructive sleep apnoea (OSA), traumatic brain injury (TBI) and concussion, lung inflammation (ARDS, COPD, asthma, bronchitis), rheumatoid arthritis, inflammatory bowel disease, anxiety disorders, addiction disorders, pain, and other indications.